Back to Agenda
Session 1: FDA Update and Potpourri
Learning Objective : At the conclusion of this session, participants should be able to:- Identify the trends reflected in the latest enforcement actions and policies issued by the FDA
- Discuss how new FDA guidances will affect the roles of medical communications, medical science liaisons, and medical writing staff
Speaker(s)
Darshan Kulkarni, JD, PHARMD, MS, RPH
Principal Attorney, Kulkarni Law Firm, PC, United States
Have an account?